ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

As China and Canada feud, vaccine maker gains favor of both

CanSino will supply COVID-19 vaccine to Chinese military while running Canadian trials

CanSino Biologics claims to be the first to publish peer-reviewed data from a clinical trial of a COVID-19 vaccine.    © Reuters

DALIAN, China -- Racing to develop a vaccine for the novel coronavirus, Chinese biotechnology company CanSino Biologics has pulled off the feat of establishing warm ties with both China and Canada at a time of fraught relations between the two countries.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more